These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
183 related items for PubMed ID: 11453805
21. Ten years experience with oral immunosuppressive treatment in adult patients with atopic dermatitis in two academic centres. Garritsen FM, Roekevisch E, van der Schaft J, Deinum J, Spuls PI, de Bruin-Weller MS. J Eur Acad Dermatol Venereol; 2015 Oct; 29(10):1905-12. PubMed ID: 25752497 [Abstract] [Full Text] [Related]
22. Prescribing practices for systemic agents in the treatment of severe pediatric atopic dermatitis in the US and Canada: The PeDRA TREAT survey. Totri CR, Eichenfield LF, Logan K, Proudfoot L, Schmitt J, Lara-Corrales I, Sugarman J, Tom W, Siegfried E, Cordoro K, Paller AS, Flohr C. J Am Acad Dermatol; 2017 Feb; 76(2):281-285. PubMed ID: 27855965 [Abstract] [Full Text] [Related]
23. Mycophenolate mofetil therapy in adult patients with recalcitrant atopic dermatitis. Dias-Polak D, Bergman R, Avitan-Hersh E. J Dermatolog Treat; 2019 Feb; 30(1):49-51. PubMed ID: 29683760 [Abstract] [Full Text] [Related]
24. The efficacy, tolerability and safety of a new oral formulation of Sandimmun--Sandimmun Neoral in severe refractory atopic dermatitis. Atakan N, Erdem C. J Eur Acad Dermatol Venereol; 1998 Nov; 11(3):240-6. PubMed ID: 9883436 [Abstract] [Full Text] [Related]
25. Treatment of severe pemphigus with a combination of immunoadsorption, rituximab, pulsed dexamethasone and azathioprine/mycophenolate mofetil: a pilot study of 23 patients. Kasperkiewicz M, Shimanovich I, Meier M, Schumacher N, Westermann L, Kramer J, Zillikens D, Schmidt E. Br J Dermatol; 2012 Jan; 166(1):154-60. PubMed ID: 21910700 [Abstract] [Full Text] [Related]
26. Oral mycophenolate mofetil as a stabilizing treatment for progressive non-segmental vitiligo: results from a prospective, randomized, investigator-blinded pilot study. Bishnoi A, Vinay K, Kumaran MS, Parsad D. Arch Dermatol Res; 2021 Jul; 313(5):357-365. PubMed ID: 32737577 [Abstract] [Full Text] [Related]
27. Sequential study on the treatment of moderate-to-severe chronic plaque psoriasis with mycophenolate mofetil and cyclosporin. Pedraz J, Daudén E, Delgado-Jiménez Y, García-Río I, García-Díez A. J Eur Acad Dermatol Venereol; 2006 Jul; 20(6):702-6. PubMed ID: 16836499 [Abstract] [Full Text] [Related]
28. A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of pemphigus. Beissert S, Werfel T, Frieling U, Böhm M, Sticherling M, Stadler R, Zillikens D, Rzany B, Hunzelmann N, Meurer M, Gollnick H, Ruzicka T, Pillekamp H, Junghans V, Luger TA. Arch Dermatol; 2006 Nov; 142(11):1447-54. PubMed ID: 17116835 [Abstract] [Full Text] [Related]
29. Vitamin D effects in atopic dermatitis. Samochocki Z, Bogaczewicz J, Jeziorkowska R, Sysa-Jędrzejowska A, Glińska O, Karczmarewicz E, McCauliffe DP, Woźniacka A. J Am Acad Dermatol; 2013 Aug; 69(2):238-44. PubMed ID: 23643343 [Abstract] [Full Text] [Related]
30. Liver enzyme abnormalities in patients with atopic dermatitis treated with mycophenolate mofetil. Hantash B, Fiorentino D. Arch Dermatol; 2006 Jan; 142(1):109-10. PubMed ID: 16415398 [No Abstract] [Full Text] [Related]
31. Analysis of correlations between patient-oriented SCORAD (PO-SCORAD) and other assessment scores of atopic dermatitis severity and quality of life. Coutanceau C, Stalder JF. Dermatology; 2014 Jan; 229(3):248-55. PubMed ID: 25196258 [Abstract] [Full Text] [Related]
32. Mycophenolate Mofetil in Severe Atopic Dermatitis: A Review. Prussick L, Plotnikova N, Gottlieb A. J Drugs Dermatol; 2016 Jun 01; 15(6):715-8. PubMed ID: 27272078 [Abstract] [Full Text] [Related]
33. [Open trial of mycophenolate mofetil in the treatment of resistant pemphigus vulgaris]. Chams-Davatchi C, Nonahal Azar R, Daneshpazooh M, Valikhani M, Hallaji Z, Barzegari M, Firouz AR, Zakeri M. Ann Dermatol Venereol; 2002 Jan 01; 129(1 Pt 1):23-5. PubMed ID: 11937925 [Abstract] [Full Text] [Related]
34. Treatment of severe chronic idiopathic urticaria with oral mycophenolate mofetil in patients not responding to antihistamines and/or corticosteroids. Shahar E, Bergman R, Guttman-Yassky E, Pollack S. Int J Dermatol; 2006 Oct 01; 45(10):1224-7. PubMed ID: 17040448 [Abstract] [Full Text] [Related]
35. Treatment of recalcitrant atopic dermatitis with the oral Janus kinase inhibitor tofacitinib citrate. Levy LL, Urban J, King BA. J Am Acad Dermatol; 2015 Sep 01; 73(3):395-9. PubMed ID: 26194706 [Abstract] [Full Text] [Related]
36. An innovative oat-based sterile emollient cream in the maintenance therapy of childhood atopic dermatitis. Mengeaud V, Phulpin C, Bacquey A, Boralevi F, Schmitt AM, Taieb A. Pediatr Dermatol; 2015 Sep 01; 32(2):208-15. PubMed ID: 25529232 [Abstract] [Full Text] [Related]
37. Alefacept for moderate to severe atopic dermatitis: a pilot study in adults. Moul DK, Routhouska SB, Robinson MR, Korman NJ. J Am Acad Dermatol; 2008 Jun 01; 58(6):984-9. PubMed ID: 18395294 [Abstract] [Full Text] [Related]
38. Enteric-coated mycophenolate sodium versus cyclosporin A as long-term treatment in adult patients with severe atopic dermatitis: a randomized controlled trial. Haeck IM, Knol MJ, Ten Berge O, van Velsen SG, de Bruin-Weller MS, Bruijnzeel-Koomen CA. J Am Acad Dermatol; 2011 Jun 01; 64(6):1074-84. PubMed ID: 21458107 [Abstract] [Full Text] [Related]
39. Hydrocortisone acetate alone or combined with mupirocin for atopic dermatitis in infants under two years of age - a randomized double blind pilot trial. Canpolat F, Erkoçoğlu M, Tezer H, Kocabaş CN, Kandi B. Eur Rev Med Pharmacol Sci; 2012 Dec 01; 16(14):1989-93. PubMed ID: 23242727 [Abstract] [Full Text] [Related]
40. Mycophenolate use in dermatology: a clinical audit. Li J, Chong AH, Green J, Kelly R, Baker C. Australas J Dermatol; 2013 Nov 01; 54(4):296-302. PubMed ID: 23574297 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]